After four weeks on the 2.5 mg dose, your healthcare provider will assess how you are feeling and decide whether to increase your dose
This is momentous news
People often look better on the drugs because they have decreased inflammation, Dayan says
Wegovy and other GLP-1 receptor agonists have also been linked to an increased risk of acute pancreatitis, gallbladder problems, acute kidney injury, low blood sugar, diabetic retinopathy complications, increased heart rate, and suicidal thoughts
For most GLP-1 receptor agonists, the answer depends on your specific medication and personal routine
Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TN therapy in inflammatory bowel disease: a 14-year experience